Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
14.78
+0.59 (+4.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Down 31% in 1 Day, What's Next for NovoCure Stock?
September 04, 2023
It's entering a risky period, but it could persevere.
Via
The Motley Fool
Why Novocure Stock Fell 24.4% This Week
August 31, 2023
Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment.
Via
The Motley Fool
Is NovoCure's Stock Headed for a Free Fall?
August 31, 2023
It can be hard to find a reason to remain bullish on NovoCure.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
August 29, 2023
On Tuesday, 99 stocks hit new 52-week lows.
Via
Benzinga
What 11 Analyst Ratings Have To Say About NovoCure
August 29, 2023
Via
Benzinga
Why NovoCure Stock Is Crashing Today
August 28, 2023
The company disappointed investors with its latest clinical trial update.
Via
The Motley Fool
Is NovoCure Stock a Buy Now?
August 09, 2023
There's nobody else angling for its market share, but that might not be enough.
Via
The Motley Fool
What's Going On With NovoCure Stock Today?
August 29, 2023
NovoCure Limited (NASDAQ: NVCR) shares are trading higher Tuesday. The stock appears to be recovering from a loss of over 30% on Monday. What To Know:
Via
Benzinga
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
August 29, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Gains Over 100 Points; Hawaiian Electric Shares Surge
August 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 34,490.80 while the NASDAQ rose 0.62% to 13,674.49. The S&P 500,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Novocure (NVCR) Stock Down 30% Today?
August 28, 2023
Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns.
Via
InvestorPlace
Why Novocure Was a Healthy Stock Today
August 08, 2023
The company stands to win big if its cancer-fighting technology does well in a late-stage clinical trial.
Via
The Motley Fool
What 9 Analyst Ratings Have To Say About NovoCure
August 04, 2023
Via
Benzinga
Why Is Cancer Focused-Novocure's Stock Plunging Today?
August 28, 2023
Novocure Ltd (NASDAQ: NVCR) shares are falling after the company's phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial of Tumor Treating Fields (TTFields) together with paclitaxel in patients...
Via
Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 28, 2023
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 28, 2023
Via
Benzinga
Crude Oil Rises; GD Culture Group Shares Spike Higher
August 28, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 150 points on Monday. The Dow traded up 0.46% to 34,505.54 while the NASDAQ rose 0.43% to 13,649.27. The S&P 500, also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
US Stocks Open Higher; Kimco Realty To Acquire RPT Realty
August 28, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 250 points on Monday. Following the market opening Monday, the Dow traded up 0.81% to 34,626.22 while the NASDAQ rose 0.61% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer
August 28, 2023
The company tested a regimen of chemotherapy and its tumor-treating fields.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 28, 2023
Via
Benzinga
Could NovoCure Stock Help You Become a Millionaire?
August 25, 2023
The stock has some significant upside, but it also comes with considerable risks and volatility.
Via
The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy in August
August 09, 2023
These two innovative growth stocks appear deeply undervalued based on their long-term potential.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
August 04, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Why Novocure Stock Tumbled by Nearly 16% Today
July 27, 2023
The company posted a notably deeper net loss in its freshly reported quarter, while its revenue fell.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.